A Day Up For Atreca, Inc.

Atreca, Inc. (BCEL:NASDAQ) jumped higher at $0.38, representing a gain of 61.1%. On Thu, Oct 12, 2023, BCEL:NASDAQ hit a New 2-Week High of $0.38. The stock got featured on our News Catalysts scanner on Thu, Sep 21, 2023 at 08:30 AM in the 'AGREEMENT' category. From Thu, Sep 28, 2023, the stock recorded 40.00% Up Days and 18.18% Green Days

The stock spiked on Thu, Oct 12, 2023 at $0.66 with a volume of 63M+.

About Atreca, Inc. (BCEL:NASDAQ)

Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.